- Selected Notes to the Consolidated Financial Statements
33
2 Highnoon Laboratories Limited
The name Highnoon, exemplifies the purpose to enrich life with perseverance, passion, integrity and reliability.
As a foundation stone of our corporate identity, our logo is the symbolic reflection of our values. On the imagery and nuances of the new mark: The bright colourful sun at the angle is a bolder and global version. It connotes the highest vibrant transmission of energy to Earth.
A deep sense of simplicity, solidity and permanence. Vim and vigour. Our boundless optimism, culminating the highest peaks. To sum up, our new mark embeds a sense of pride, unity, hope and belonging in all of us.
Dr. Adeel Abbas
Chief Executive Officer
Q3 Report 2022 3
COMPANY INFORMATION
Board of Directors
Mr. Tausif Ahmad Khan
Chairman
Dr. Adeel Abbas Haideri
Chief Executive Officer
Mrs. Zainub Abbas
Mrs. Nael Najam
Mr. Ghulam Hussain Khan
Mr. Taufiq Ahmed Khan
Mr. Romesh Elapata
Chief Financial Officer
Mr. Ashfaq P. Alidina Tel : +92 42 3751 1953 Email : ashfaq.alidina@highnoon. com.pk
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Highnoon Laboratories Ltd. published this content on 31 October 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 October 2022 05:08:06 UTC.
Highnoon Laboratories Limited is a Pakistan-based company that is engaged in the manufacturing, importing, selling and marketing of pharmaceutical and allied consumer products. The Company's product categories include cardiology, metabolic, gastroenterology, musculoskeletal, anti-infective, obstetrics and gynecology, pediatrics, allergy, respiratory, and urology. Its cardiology products include Somno, Hitica, Apiban, Pidogrel-AP, Blokium DIU, Epliron, Sacuvia, Ivaset, Rivaro, Valforge and Herbesser. Its metabolic products include Xormet XR, MetFormin HCI, Diajard-MXR, Diajard-M and Diajard. The Company's gastroenterology products include Liv 52, Rabecid and Racedo. Its musculoskeletal products include Flexa Plus, Airtal ER and Tamadol. The Company's pediatric products include Bonisan, Cogniza, Flu Ace, Prospan and Tres Orix Forte. Its allergy products include Leviva and Kestine. Its Respiratory products include Combivair Forte, Sprahaler Respules, Foracort HFA Inhaler and Rotaflo.
HIGHNOON LABORATORIES LIMITED 
